Anticorps monoclonaux en cardiologie.

Angina, Unstable/drug therapy; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal/therapeutic use; Coronary Thrombosis/drug therapy; Humans; Immunoglobulin Fab Fragments/therapeutic use; Myocardial Infarction/drug therapy; Platelet Aggregation Inhibitors/therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors

Abstract :

[en] Clinical efficacy of antiplatelet agents administration to reduce ischemic complications has supported the concept of atherothrombosis and plaque rupture. Specifically, administration of monoclonal antibody against platelet membrane receptor glycoprotein IIb/IIa was shown to be highly effective whenever percutaneous intervention is performed in the setting of unstable coronary syndrome. The in-hospital use of glycoprotein IIb/IIIa is unanimously recommended in these situations.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Legrand, Victor ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie

Language :

French

Title :

Anticorps monoclonaux en cardiologie.

Alternative titles :

[en] Monoclonal antibodies in cardiology

Publication date :

2009

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

5-6

Pages :

310-2

Peer reviewed :

Peer reviewed

Available on ORBi :

since 21 June 2014

Statistics

Number of views

74 (1 by ULiège)

Number of downloads

104 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Ross R. - The pathogenesis of atherosclerosis : a perspective for the 1990's. Nature, 1993, 362, 801-809.
Libby P. - Inflammation in atherosclerosis. Nature, 2002, 420, 868-874.
Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ, 2002, 324, 71-86. (Pubitemid 34073138)
Kleiman NS. - GP IIb/IIa antagonists. Clinical experience and potential use in cardiology. Drugs R D, 1999, 1, 361.
The Task Force for the Diagnosis and Treatment of Non ST-Segment Elevation Acute Coronary Syndrome of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J, 2007, 28, 1598-1660.
The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J, 2008, 29, 2909-2945.
The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. Eur Heart J, 2005, 26, 804-847.